About This Course

Made in collaboration with Myeloma UK, this eLearning course is for healthcare professionals. It has been designed to teach you everything you need to know about AL Amyloidosis. Topics include epidemiology, pathophysiology, diagnosis, staging and management.

Myeloma UK is the only charity in the UK that focuses on the blood cancer myeloma and its related conditions. This patient association support research to treat myeloma as well as support patients who suffer from myeloma.

This course should take you approximately 60 minutes to complete.

This course has been accredited by the Royal College of Pathologists and awarded 1 CPD point.


This course has a 2-year expiry date of 23 June 2025. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed.  


Learning Outcomes

By the end of this course, learners will be able to:

  • define AL amyloidosis.

  • list the diagnostic features of AL amyloidosis.

  • explain the goals of treatment for AL amyloidosis.

  • describe the factors that influence treatment decisions.

Course curriculum

    1. Welcome to the Course

    1. Introduction to Pre-Course Quiz

    2. Pre-Course Quiz

    1. Identification of AL Amyloidosis

    1. Diagnosis of AL Amyloidosis

    1. Management of AL Amyloidosis

    1. Introduction to Quiz

    2. Final Quiz

    1. Conclusions and Take-Home Messages

    2. Course Feedback Survey

About this course

  • Free
  • 10 lessons
  • 0 hours of video content

Expert Faculty

Prof. Ashutosh Wechalekar, Professor of Medicine and Haematology, University College London and the Royal Free London NHS Foundation Trust, UK

Dr. Christopher Parrish, Consultant Haematologist, Leeds Teaching Hospitals NHS Trust, UK

Prof. Efstathios Kastritis, Professor of Clinical Therapeutics/Medical Oncology, National and Kapodistrian University of Athens, School of Medicine, Greece

Dr. Jennifer Pinney, Consultant Nephrologist, University Hospitals Birmingham NHS Foundation Trust, UK

Dr. Carol Whelan, Consultant Cardiologist, Royal Free London NHS Foundation Trust, UK

Prof. Giovanni Palladini, Acting Director of the Amyloidosis Research and Treatment Center, University Hospital San Matteo, Pavia, Italy

Prof. Guy Pratt, Consultant Haematologist, University Hospitals Birmingham, UK